GPT Healthcare Ltd

Q1 FY27Healthcare Services

GPT Healthcare Ltd Q1 FY27 Results & Concall Highlights: Revenue, Margins & Order Book

Q1 FY27 earnings call: what management guided on revenue, margins and order book.

Price₹150

Market cap₹1.3K Cr

P/E27.1

Updated25 Aug 2026

Read4 min read

What the Q1 FY27 call signalled

3 of 4 strong

RevenueRank 3

MarginRank 1

CapexYes

FundraiseYes

Not discussed on this call: order book.

The short version

GPT Healthcare expects continued revenue growth driven by higher occupancy and improved specialty mix across hospitals. GPT Healthcare expects EBITDA margins to improve from 19% last year to around 21% in FY27, translating to an EBITDA of approximately INR 110-115 crores annually (including other income).

From GPT Healthcare Ltd's Q1 FY27 earnings-call transcript · updated 25 Aug 2026.

Revenue & Sales Performance

Rank 3

GPT Healthcare expects continued revenue growth driven by higher occupancy and improved specialty mix across hospitals.
Mature hospitals show steady patient inflows with network occupancy at 45.5%, and 58.07% in mature hospitals excluding Raipur.
Expansion projects like the 155-bed Jamshedpur hospital commissioning in Q4 FY27 and plans for a seventh hospital will increase capacity beyond 1,000 beds in 2 years.
Specialty services, including liver transplants (around 10 per year initially at Raipur), oncology ramp-up, and robotic surgeries, are expected to drive higher ARPOB and patient volumes.
Newer hospitals like Raipur and Dumdum are ramping up occupancy and revenue, with Dumdum targeting optimum occupancy by Q3 FY27.
International patient inflows from Bangladesh are improving but expected to normalize fully in 6 months, adding to growth.
Overall, the company targets sustainable earnings growth, aiming for around 21% EBITDA margin and ROE/ROCE of ~25% over medium term.

Profitability & Margins

GPT Healthcare expects EBITDA margins to improve from 19% last year to around 21% in FY27, translating to an EBITDA of approximately INR 110-115 crores annually (including other income).
Profit after tax for Q1 FY27 stood at INR 12.7 crores with a PAT margin of 9.9%, reflecting strong growth and resilience.
The company targets long-term ROE and ROCE of around 25%, driven by occupancy improvement, specialty mix optimization, and asset-light expansion.
New hospital ramps (Raipur, Jamshedpur) and expansion plans for a 7th hospital will drive network growth beyond 1,000 beds over 2 years.
Growth supported by higher ARPOB led by specialty care, optimized occupancy, and innovative services like robotic surgeries and transplant programs.
Profitability expected to improve as Raipur's losses taper and Jamshedpur hospital ramps up, with historical breakeven achieved in 12-20 months for new hospitals.

See what GPT Healthcare Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Yes

GPT Healthcare is progressing on the construction of a 155-bed tertiary care hospital in Jamshedpur, expected to be commissioned in Q4 FY27.
The company is evaluating opportunities for a seventh hospital, aiming to increase network capacity to over 1,000 beds in the next 2 years.
Expansion plans include both acquisition and greenfield projects in Tier 1 and Tier 2 cities like Cuttack, Ranchi, Patna, Banaras, and Prayagraj.
New hospitals such as Raipur and Jamshedpur are developed on an asset-light model, leasing customized buildings to reduce real estate investments.
GPT Healthcare is investing in advanced medical technologies, strengthening high-acuity specialties, and expanding transplant programs.
Focus remains on disciplined growth through capacity expansion, stronger clinical capabilities, and prudent capital allocation.

Top-ranked in Healthcare Services

Ranked on what management guided this quarter

5x potential

1Health X Platform₹981 Cr

Rev 1Mar 1

2CHANDAN₹518 Cr

Rev 1Mar 3

3₹66.5K Cr

Rev 2Mar 1

4₹654 Cr

Rev 2Mar 2

5₹1.3L Cr

Rev 2Mar 3

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

No significant change in debt position compared to last year; debt remains stable.
Jamshedpur hospital project will incur additional debt of around INR 25 crores in the current fiscal year.
No specific mention of raising equity or new fundraising plans during the call.
Future expansion (7th hospital) may involve acquisitions or greenfield projects; no direct indication of fundraising method disclosed.
The company maintains a healthy balance sheet and focuses on disciplined capital allocation.
Overall, plans rely on prudent capital use rather than immediate large-scale fundraising through debt or equity.

See what GPT Healthcare Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The transcript does not explicitly mention details about the current or expected order book or pending orders for GPT Healthcare Limited. However, relevant insights include: - The company is progressing with the construction of a 155-bed tertiary care hospital at Jamshedpur, expected to be commissioned in Q4 FY27. - Evaluation of opportunities for a seventh hospital is ongoing, targeting Tier 1 and Tier 2 cities like Cuttack, Ranchi, Patna, Banaras, and Prayagraj. - Both greenfield and acquisition opportunities are being considered, with no definitive order or project confirmed yet. - Asset-light models are being used for new hospitals like Raipur and Jamshedpur to reduce capital investment. Therefore, while active projects and expansions are in the pipeline, there is no specific mention of an order book or pending orders figure in the transcript.

GPT Healthcare Ltd — Quarterly revenue & net profit

Revenue Net profit

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹126 Cr, net profit ₹15 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What GPT Healthcare Ltd's management said in earlier quarters

Others in Healthcare Services this season

Manipal Health Enterprises Ltd (Q1 FY27)
Volume-led growth with inpatient (IP) volumes up 39% and outpatient (OP) volumes up 26% year-on-year. Key concall takeaways from Manipal Health Enterprises…
Fortis Healthcare Ltd (Q1 FY27)
IHH plans to increase its stake in Fortis to over 50% within 3-5 years, supporting long-term strategic growth. Key concall takeaways from Fortis Healthcare…
Metropolis Healthcare Ltd (Q1 FY27)
East India currently 6%, with limited investment so far; future investments may increase contribution. Key concall takeaways from Metropolis Healthcare Ltd's…
Apollo Hospitals Enterprise Ltd (Q1 FY27)
IP volume growth for established units guided at roughly 7% to 8%. Key concall takeaways from Apollo Hospitals Enterprise Ltd's Q1 FY27 earnings call — and how…

Compare:vs Apollo Hospitals Enterprise Ltd vs Max Healthcare Institute Ltd vs Manipal Health Enterprises Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were GPT Healthcare Ltd Q1 FY27 results?

What is GPT Healthcare Ltd share price analysis?

GPT Healthcare Ltd currently shows a below-average growth signal. The stock trades at a P/E of 27.1 with a market cap of ₹1,281 Cr. Investors should review the full earnings analysis for detailed insights.

Is GPT Healthcare Ltd planning capital expenditure?

GPT Healthcare is progressing on the construction of a 155-bed tertiary care hospital in Jamshedpur, expected to be commissioned in Q4 FY27.

Keep GPT Healthcare Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.